Mode
Text Size
Log in / Sign up
Phase 3 Completed N=861 Randomized Double-blind Treatment

Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers

Source: ClinicalTrials.gov NCT00586625 ↗
Enrolled (actual)
861
Serious AEs
0.0%
Results posted
Nov 2009
Primary outcomePrimary: Ocular Comfort — 0.13; 0.07; 0.06; 0.02 Scores on a scale

Summary

Safety study for bepotastine besilate ophthalmic solution in normal volunteers

Outcome Measures

OutcomeResultp-value
PRIMARY
Ocular Comfort
0.13; 0.07; 0.06; 0.02; 0.1; 0.06

Eligibility Criteria

Inclusion Criteria

  • Subjects must be at least 3 years of age, and have ocular health within normal limits

Exclusion Criteria

  • No active ocular disease
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00586625). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search